Sub-setting and Indication Stacking in Orphan Drugs: a Recipe for the Future of Exclusive Rights

The present article is, apart from the result of my own work and intellectual effort, also written for a special occasion. Professor Marianne Levin has turned a healthy age, and I have been asked by the current esteemed colleagues at the Stockholm Law Faculty to write a contribution for this special occasion. Scheduling this piece of work into my calendar was difficult, due to a list of other commitments, but I could not possibly refuse the honour, so I accepted. The reader might wonder how Professor Marianne Levin and I could possibly be linked.